{"id":"https://openalex.org/W1964048276","doi":"https://doi.org/10.1016/j.antiviral.2008.10.007","title":"Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics","display_name":"Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics","publication_year":2008,"publication_date":"2008-11-22","ids":{"openalex":"https://openalex.org/W1964048276","doi":"https://doi.org/10.1016/j.antiviral.2008.10.007","mag":"1964048276","pmid":"https://pubmed.ncbi.nlm.nih.gov/19027039"},"language":"en","primary_location":{"id":"doi:10.1016/j.antiviral.2008.10.007","doi":"https://doi.org/10.1016/j.antiviral.2008.10.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.antiviral.2008.10.007","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071339903","display_name":"Koichiro Nakahara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koichiro Nakahara","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008379236","display_name":"Chiaki Wakasa-Morimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chiaki Wakasa-Morimoto","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043194092","display_name":"Masanori Kobayashi","orcid":"https://orcid.org/0000-0003-4045-3103","observed_orcids":["https://orcid.org/0000-0003-4045-3103"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masanori Kobayashi","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038814610","display_name":"Shigeru Miki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeru Miki","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018757118","display_name":"Takeshi Noshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeshi Noshi","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101790533","display_name":"Takahiro Seki","orcid":"https://orcid.org/0000-0002-3952-8684","observed_orcids":["https://orcid.org/0000-0002-3952-8684"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takahiro Seki","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068501657","display_name":"Mikiko Kanamori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mikiko Kanamori-Koyama","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001206349","display_name":"Shinobu Kawauchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinobu Kawauchi","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042238455","display_name":"Akemi Suyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akemi Suyama","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079310840","display_name":"Toshio Fujishita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshio Fujishita","raw_affiliation_strings":["Medicinal Chemistry, Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069012570","display_name":"Tomokazu Yoshinaga","orcid":"https://orcid.org/0000-0001-5578-2212","observed_orcids":["https://orcid.org/0000-0001-5578-2212"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomokazu Yoshinaga","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110166075","display_name":"Edward P. Garvey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward P. Garvey","raw_affiliation_strings":["Virology, Infectious Disease Center of Excellence for Drug Discovery, GlaxoSmithKline, Research Triangle Park, NC 27709, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Infectious Disease Center of Excellence for Drug Discovery, GlaxoSmithKline, Research Triangle Park, NC 27709, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048833977","display_name":"Brian A. Johns","orcid":"https://orcid.org/0000-0001-5526-3682","observed_orcids":["https://orcid.org/0000-0001-5526-3682"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian A. Johns","raw_affiliation_strings":["Medicinal Chemistry, Infectious Disease Center of Excellence for Drug Discovery, GlaxoSmithKline, Research Triangle Park, NC 27709, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Infectious Disease Center of Excellence for Drug Discovery, GlaxoSmithKline, Research Triangle Park, NC 27709, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015151871","display_name":"Scott A. Foster","orcid":"https://orcid.org/0000-0002-2773-7999","observed_orcids":["https://orcid.org/0000-0002-2773-7999"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott A. Foster","raw_affiliation_strings":["Virology, Infectious Disease Center of Excellence for Drug Discovery, GlaxoSmithKline, Research Triangle Park, NC 27709, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Infectious Disease Center of Excellence for Drug Discovery, GlaxoSmithKline, Research Triangle Park, NC 27709, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056086220","display_name":"Mark Underwood","orcid":"https://orcid.org/0000-0002-6803-2346","observed_orcids":["https://orcid.org/0000-0002-6803-2346"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark R. Underwood","raw_affiliation_strings":["Virology, Infectious Disease Center of Excellence for Drug Discovery, GlaxoSmithKline, Research Triangle Park, NC 27709, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Infectious Disease Center of Excellence for Drug Discovery, GlaxoSmithKline, Research Triangle Park, NC 27709, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041689745","display_name":"Akihiko Sato","orcid":"https://orcid.org/0000-0001-6625-1679","observed_orcids":["https://orcid.org/0000-0001-6625-1679","https://orcid.org/0009-0008-0753-4394"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Akihiko Sato","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110083853","display_name":"Tamio Fujiwara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tamio Fujiwara","raw_affiliation_strings":["Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Shionogi Research Laboratories, Shionogi & Co., Ltd., 2-5-1, Mishima, Settsu-shi, Osaka 566-0022, Japan","institution_ids":["https://openalex.org/I4210118477"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5041689745"],"corresponding_institution_ids":["https://openalex.org/I4210118477"],"apc_list":{"value":4160,"currency":"USD","value_usd":4160},"apc_paid":null,"fwci":4.7233,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.94549819,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"81","issue":"2","first_page":"141","last_page":"146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11764","display_name":"Evolution and Genetic Dynamics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-integrase-inhibitors","display_name":"HIV-1 integrase inhibitors","score":0.9559999704360962},{"id":"https://openalex.org/keywords/secondary-mutations","display_name":"secondary mutations","score":0.9129999876022339},{"id":"https://openalex.org/keywords/viral-fitness","display_name":"viral fitness","score":0.7599999904632568},{"id":"https://openalex.org/keywords/virus-infectivity","display_name":"viral infectivity","score":0.8799999952316284},{"id":"https://openalex.org/keywords/replication-kinetics","display_name":"replication kinetics","score":0.8199999928474426},{"id":"https://openalex.org/keywords/double-mutant","display_name":"double mutants","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.8959262371063232},{"id":"https://openalex.org/C106358424","wikidata":"https://www.wikidata.org/wiki/Q1662346","display_name":"Infectivity","level":3,"score":0.7853977680206299},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7441577315330505},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.6760119199752808},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.6510583162307739},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6435800194740295},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.5470446348190308},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.5169619917869568},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.4691570997238159},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.43527764081954956},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.36757683753967285},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.29239994287490845},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2116902768611908},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.1974005103111267},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.1570417582988739},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.0863722562789917},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D005663","descriptor_name":"Furans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D019169","descriptor_name":"Jurkat Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019427","descriptor_name":"HIV Integrase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019427","descriptor_name":"HIV Integrase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020125","descriptor_name":"Mutation, Missense","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.antiviral.2008.10.007","doi":"https://doi.org/10.1016/j.antiviral.2008.10.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.antiviral.2008.10.007","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},{"id":"pmid:19027039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19027039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320323316","display_name":"Shionogi","ror":"https://ror.org/01v3bqg10"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W180725227","https://openalex.org/W1517131856","https://openalex.org/W1534668915","https://openalex.org/W1659719610","https://openalex.org/W1989276338","https://openalex.org/W2007831756","https://openalex.org/W2030854058","https://openalex.org/W2053125329","https://openalex.org/W2069815189","https://openalex.org/W2071622591","https://openalex.org/W2084895970","https://openalex.org/W2089583823","https://openalex.org/W2101092816","https://openalex.org/W2104937944","https://openalex.org/W2126821063","https://openalex.org/W2128944251","https://openalex.org/W2131567422","https://openalex.org/W2141675394","https://openalex.org/W2145928000","https://openalex.org/W2164778451","https://openalex.org/W2166420278","https://openalex.org/W6607400712","https://openalex.org/W6668659511"],"related_works":["https://openalex.org/W2046412323","https://openalex.org/W1667485879","https://openalex.org/W7097579527","https://openalex.org/W2318124317","https://openalex.org/W1976408158","https://openalex.org/W2044794863","https://openalex.org/W2084545711","https://openalex.org/W3032152409","https://openalex.org/W4288066431","https://openalex.org/W7100073732"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}